The UK's first patient-focused event of its kind, saw 90 women and men from our community come together to hear first-hand from a number of experts in the medical field about how to navigate and understand clinical guidelines, and how to live well alongside secondary breast cancer. We were also delighted to be joined by over 400 people online.
Our speakers came from various walks of medical life and discussed a variety of subjects with live Q&A sessions at the end. We saw informative talks from Sarah Adomah, Lead Breast Clinical Nurse Specialist at The Royal Marsden about coping with side effects; the latest in TBNB developments from Dr Sheeba Irshad, Breast Cancer Medical Oncologist at Guy's & St Thomas' NHS Trust; and an understanding of Palliative Care from consultant Dan Monnery.
Toral Shah, Nutritional Scientist & Integrative Medicine Practitioner spoke about living well with secondary breast cancer; Research Therapeutic Radiographer Naman Julka-Anderson explained the various targeted treatments; and our Lead Patient Trials Advocate nurse Vivienne explained clinical trials and when to think about them.
SBC Sumitt Attendee feedback:
“It sounds dramatic but attending events like this summit changes lives! I had a voice, I was heard and I felt validated, that is powerful. Make 2nds Count is my go to for support, education, resources, friendship, advice and community. ( and so much more) By putting together this summit M2C have given me a fantastic opportunity to further my knowledge and to give me confidence to be a better advocate for my future. I would really encourage everyone to apply for the next summit. It will change your life for the better’
The Secondary Breast Cancer Patient Summit is the pinnacle of the work of Make 2nds Count, sitting across all three pillars of what the charity does: support, education and research. We hope to be able to make this an annual event so more of the Secondary (metastatic) Breast Cancer community will have the opportunity to attend in-person or online.
WATCH THE LIVE RECORDINGS BELOW
In partnership with:
Funding Partners
Thanks to our funding partners AstraZeneca UK ltd, Gilead Sciences ltd, Menarini Stemline Oncology, MSD, Novartis Pharmaceuticals UK ltd, 100 patient places are available, with accommodation and catering fully provided and a travel fund available to those who need support with travel expenses.